Clinical Trial Update: Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial of everolimus in older patients with mantle cell lymphoma previously treated with first- or second-line chemotherapy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Afinitor (everolimus)

Snippet

Sponsor: Technical University of Munich | Conditions: Lymphoma | Phase 2 | Status: TERMINATED